United Therapeutics: all 103 studies
Page 2 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian CarcinomaTerminatedNCT00034372Phase 2
- A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial CarcinomaTerminatedNCT00034138Phase 1/2
- Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary HypertensionCompletedNCT00004497Phase 3